Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin 20% injection versus oral egg white for hypoalbuminemia management in ICU patients
IRCT20240707062349N3Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Apr 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-blind trial of albumin (human) and egg white protein in hypoalbuminemia (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Albumin level and Prealbumin level. Started Apr 2025; status: completed.
02
Drugs
albumin (human)egg white protein
03
Conditions
hypoalbuminemia
Beyond the preview
Go deeper on IRCT20240707062349N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240707062349N3.